1Lichtinghagen R, Seifert T, Kracke A, et al. Expression of matrixmetalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with atherosclerosis. Circulation,2000,98 ( 1 ) :83-91.
2Kieseier BC, Paul R, Koedel U ,et al. Differential expression of matrixmetalloproteinases in cardiovascular diseases. Brain, 2002, 122 ( 8 ) : 1579-1586.
3Patel SS, Thiagarajan R, Willerson JT, et al, Inhibition of alpha4 integrin and ICAM-1 markedly attenuate macrophage to atheroselerotic plaques in ApoE-deficient mice, Circulation, 1999,97(2 ) :75-81.
4Itoh T,Tanioka M, Matsuda H ,et al. Experimental metastasisis suppressed in MMP-9-deficient mice. Clin Exp Metastasis, 1999,17 (2) : 177-179.
5Rosenson RS, Tangney CC. Antiatherothrombotic properties of statins :implications for cardiovascular event reduction. JAMA, 1998,279(4) : 1643-1650.
5Srabasti J. Chakravorty, Alister Craig. The role of ICAM - 1 in Plasmodium falciparum cytoadherence [ J]. Eurpean Journal of Cell Biology,2005,84 : 15-27.
6MYERS CL,WERTHEIMER SJ,SCHEMBRIC. KING J,et al. Induction of ICAM - 1 by TNF - α, IL - 1 B and LPS in human endothelial cells after downreguLation of PKC [ J ]. Am J Physiol, 1992,263 (4 Pt1) : C767-C772.
7ACC/AHA. Guideline update for the management of patients with unstable angina and non ST segment elevation myocardial infarction 2002: summary article [ J]. Circulation, 2002, 106 ( 12 ) : 1893- 1900.
